“As a regionally focused pharmaceutical company, a major challenge we face is bringing innovative medicines to patients and healthcare providers that are both appropriate and brought forward in the right time. Knowing the individual backgrounds of the [Naia] management team, combined with the approach of the business model, it was immediately evident the right components where in place that could help Pharco to make a difference in emerging markets such as Egypt.”
Dr Sherine Helmy
Co-Founder and investor
Naia Board of Directors
Sherine Helmy, Pharm Bsc MBA DBA, has 30 years of experience in the pharmaceutical industry and is the chief executive officer of Pharco Pharmaceuticals.
He is also vice president and managing director of Baterjee Pharmaceuticals, vice president and managing director of Beovita Gmbh in Germany, vice president of Hassan Abbas Helmy Institute for Social Affairs, and a consultant to TOANO in Belgium.
He is involved with a number of organizations related to the pharmaceutical industry and economic growth in Egypt. He serves as a board member of Alexandria University, the Egyptian Japanese University of Technology (EJUST), the National Authority for Quality Assurance and Accreditation of Education (NAQAAE), the Egyptian Accreditation Council (EGAC), the Supreme Council for Culture- Committee of Management Sciences, the New Borg El Arab City Culture Palace, and a founding member of North Coast University (NCU).
He earned a BSc in pharmacy from Alexandria University, an MBA from the Arab Academy for Science & Technology (AAST)/Central Michigan University, and a Doctorate of Business Administration (DBA) from AAST.